Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.

Clinical Interventions in Aging
Natasha JordanEithne Murphy

Abstract

Postmenopausal osteoporosis is a common clinical entity; its complications represent a significant burden to society. In recent years the choice of therapies available for the treatment of postmenopausal osteoporosis has increased dramatically. There are a number of antiresorptive agents currently available including hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), bisphosphonates, and dual action bone agents. It is difficult to truly compare these therapies given the lack of direct head-to head studies. The efficacy of antiresorptive therapies can be assessed in a number of ways including measurement of bone mineral density (BMD), assessment of bone turnover markers, and fracture reduction. Other important factors include ease of administration and consequent patient compliance. This article reviews the currently available antiresorptive agents and their effects on the above outcome measures.

References

Jul 1, 1992·Annals of Internal Medicine·E G LufkinB L Riggs
Oct 1, 1990·The Journal of Clinical Endocrinology and Metabolism·C Christiansen, B J Riis
Jun 15, 1996·The Journal of Clinical Investigation·G A Rodan, H A Fleisch
Nov 1, 1996·The American Journal of Medicine·J R TucciA C Santora
Apr 9, 1997·JAMA : the Journal of the American Medical Association·D B KarpfD Thompson
Apr 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S GonnelliC Gennari
Aug 18, 1997·The American Journal of Medicine·P D Ross
Nov 3, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E G LufkinB L Riggs
Jan 6, 1999·JAMA : the Journal of the American Medical Association·R P Heaney
May 18, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P Dolan, D J Torgerson
Nov 7, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H A PolsB Stych
Feb 25, 2000·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·S P NielsenP J Meunier
Feb 29, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P J MeunierM W Draper
Mar 25, 2000·JAMA : the Journal of the American Medical Association·M R Goldstein
Nov 30, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Feb 15, 2001·The New England Journal of Medicine·M R McClungUNKNOWN Hip Intervention Program Study Group
Jun 2, 2001·The New England Journal of Medicine·K L Sauder
Oct 5, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·G B StroupM Gowen
Mar 1, 2002·The New England Journal of Medicine·Ian R ReidPierre J Meunier
Jul 11, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R P HeaneyC H Chesnut
Aug 15, 2002·European Journal of Pharmacology·Roland Baron, Yannis Tsouderos
Dec 3, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J Y ReginsterC Roux
Jan 28, 2003·Cleveland Clinic Journal of Medicine·Chad L Deal
Jun 24, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R EastellP D Delmas
Jun 24, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·N TakahashiT Suda
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Sep 23, 2003·The New England Journal of Medicine·Dennis M BlackUNKNOWN PaTH Study Investigators
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Jane A CauleyUNKNOWN Women's Health Initiative Investigators
Oct 8, 2003·Current Pharmaceutical Design·Michael J Rogers
Nov 12, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Robert S WeinsteinDouglas B Muchmore
Jan 30, 2004·The New England Journal of Medicine·Pierre J MeunierJean-Yves Reginster
Mar 19, 2004·The New England Journal of Medicine·Henry G BoneUNKNOWN Alendronate Phase III Osteoporosis Treatment Study Group

❮ Previous
Next ❯

Citations

Aug 30, 2013·Journal of Translational Medicine·Gillian WheaterJacob M van Laar
Dec 8, 2017·Clinical Reviews in Bone and Mineral Metabolism·M GundryK Knapp
Feb 18, 2011·Journal of Experimental Botany·Zoe A WilsonCaiyun Yang
Jul 16, 2020·International Journal of Molecular Sciences·Linda SequeiraAnja Nohe

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
hormone replacement therapy
biopsies
hormone replacement therapies
biopsy

Software Mentioned

MOBILE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.